Formaldehyde → HCID 44816057, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[C:9]1[N:10]2[N:18]=[C:17]([CH3:19])[CH:16]=[C:11]2[O:12][C:13]=1[CH2:14][CH3:15].[CH2:20]([NH:23][CH2:24][CH2:25][CH3:26])[CH2:21][CH3:22].[CH2:27]=O>CC(O)=O>[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[C:9]1[N:10]2[N:18]=[C:17]([CH3:19])[C:16]([CH2:27][N:23]([CH2:24][CH2:25][CH3:26])[CH2:20][CH2:21][CH3:22])=[C:11]2[O:12][C:13]=1[CH2:14][CH3:15]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 50 °C
Procedure
To a solution of 3-(2,4-dichloro-phenyl)-2-ethyl-6-methyl-pyrazolo[5,1-b]oxazole (Intermediate HO)(30 mg, 0.10 mmol, 1 eq.) and dipropylamine (0.042 ml, 0.31 mmol, 3 eq.) in AcOH (0.3 ml) is added formaldehyde (36.5% in water, 0.025 ml, 0.31 mmol, 3 eq.) at RT. The reaction mixture is heated at 50° C. for 2 h then cooled to RT and directly subjected to purification by reverse phase prep-HPLC (Waters system) to yield the title compound (TFA salt) as a colourless resin. HPLC: AtRet=1.89; MS: m/z 408.1 [M+H]+; 1H NMR (400 MHz, DMSO-d6) δ 0.96 (t, 6H), 1.22 (t, 3H), 1.73-1.83 (m, 4H), 2.30 (s, 3H), 2.68 (q, 2H), 2.96-3.05 (m, 4H), 4.34 (m, 2H), 7.68 (m, 2H), 7.93 (m, 1H).
Workup
- temperaturethen cooled to RT
- customdirectly subjected to purification by reverse phase prep-HPLC (Waters system)
Sources & evidence
- ORD record
- ord-9de1938a7476493297c3259b4a938e29
- Source dataset
- uspto-grants-2011_08
- Patent number
- US07994203B2
Reaction notes
Loading…